Leukemia
General Information
A Phase III Randomized Trial for Patients with de novo AML using Bortezomib and Sorafenib (IND#114480; NSC#681239, NSC#724772) for Patients with High Allelic Ratio FLT3/ITD
Pediatrics
AAML1031
Inova Children's Hospital
3300 Gallows Road
Falls Church, VA 22042
Eligibility Information
Ineligibility Information